Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China flag China · Delayed Price · Currency is CNY
16.93
+0.25 (1.50%)
Apr 28, 2026, 3:00 PM CST

SHA:601607 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Operating Revenue
282,552274,187259,152231,240215,824
Upgrade
Other Revenue
1,0271,0641,143741.24-
Upgrade
Revenue
283,580275,251260,295231,981215,824
Upgrade
Revenue Growth (YoY)
3.03%5.75%12.21%7.49%12.46%
Upgrade
Cost of Revenue
253,207244,837229,366201,604187,416
Upgrade
Gross Profit
30,37330,41330,92930,37728,408
Upgrade
Selling, General & Admin
18,45818,32619,52719,17318,376
Upgrade
Research & Development
2,3402,3942,2042,1121,987
Upgrade
Other Operating Expenses
640.28143.51376.86654.72633.18
Upgrade
Operating Expenses
21,91021,09622,34922,21420,942
Upgrade
Operating Income
8,4639,3178,5818,1647,466
Upgrade
Interest Expense
-1,686-1,857-1,885-1,689-1,518
Upgrade
Interest & Investment Income
3,575902.81461.83971.412,150
Upgrade
Currency Exchange Gain (Loss)
-62.04-73.9311.4121.5110.1
Upgrade
Other Non Operating Income (Expenses)
-168.04-166.21-109.59-116.44-128.71
Upgrade
EBT Excluding Unusual Items
10,1228,1237,0597,3517,979
Upgrade
Impairment of Goodwill
-328.53-230.47---19.21
Upgrade
Gain (Loss) on Sale of Investments
332.12178.43155.93218.74-206
Upgrade
Gain (Loss) on Sale of Assets
157.15187.9792.481,43958.29
Upgrade
Asset Writedown
-707.97-218.05-70.65-322.79-69.77
Upgrade
Legal Settlements
-46.79-26.56-12.69-37.38-8.1
Upgrade
Other Unusual Items
292.175.56-169.95160.13409.61
Upgrade
Pretax Income
9,8208,0207,0548,8088,144
Upgrade
Income Tax Expense
2,8462,1501,8881,8161,869
Upgrade
Earnings From Continuing Operations
6,9745,8705,1676,9926,275
Upgrade
Minority Interest in Earnings
-1,249-1,317-1,399-1,375-1,181
Upgrade
Net Income
5,7254,5533,7685,6175,093
Upgrade
Net Income to Common
5,7254,5533,7685,6175,093
Upgrade
Net Income Growth
25.75%20.82%-32.92%10.28%13.28%
Upgrade
Shares Outstanding (Basic)
3,7083,7043,7013,4832,842
Upgrade
Shares Outstanding (Diluted)
3,7083,7043,7013,4832,842
Upgrade
Shares Change (YoY)
0.11%0.07%6.28%22.54%-
Upgrade
EPS (Basic)
1.541.231.021.611.79
Upgrade
EPS (Diluted)
1.541.231.021.611.79
Upgrade
EPS Growth
25.30%20.73%-36.77%-10.06%13.29%
Upgrade
Free Cash Flow
3,8283,4262,2612,058942.55
Upgrade
Free Cash Flow Per Share
1.030.930.610.590.33
Upgrade
Dividend Per Share
0.4700.3700.4100.6100.420
Upgrade
Dividend Growth
27.03%-9.76%-32.79%45.24%-12.50%
Upgrade
Gross Margin
10.71%11.05%11.88%13.10%13.16%
Upgrade
Operating Margin
2.98%3.38%3.30%3.52%3.46%
Upgrade
Profit Margin
2.02%1.65%1.45%2.42%2.36%
Upgrade
Free Cash Flow Margin
1.35%1.24%0.87%0.89%0.44%
Upgrade
EBITDA
10,45211,01510,0819,6898,973
Upgrade
EBITDA Margin
3.69%4.00%3.87%4.18%4.16%
Upgrade
D&A For EBITDA
1,9901,6981,5001,5261,507
Upgrade
EBIT
8,4639,3178,5818,1647,466
Upgrade
EBIT Margin
2.98%3.38%3.30%3.52%3.46%
Upgrade
Effective Tax Rate
28.98%26.81%26.76%20.62%22.95%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.